Montelukast Sodium Pinewood Laboratories

Montelukast sodium, the active ingredient in Montelukast Pinewood Laboratories, is a leukotriene receptor antagonist presented as an oral dosage form for oral use. It is used to treat asthma, allergic rhinitis and exercise‑induced bronchoconstriction in adults and children.

GNH USA supplies Montelukast Pinewood Laboratories as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Montelukast sodium is a leukotriene receptor antagonist used in respiratory and allergic conditions. - Asthma: provides maintenance therapy to reduce frequency and severity of symptoms. - Allergic rhinitis: relieves nasal congestion, sneezing and itching. - Exercise‑induced bronchoconstriction: prevents bronchospasm triggered by physical activity.

Montelukast sodium may cause a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often transient. - Abdominal pain: discomfort or cramping in the stomach area. - Cough: occasional dry cough. - Nausea: feeling of sickness or urge to vomit. - Dizziness: light‑headed sensation. - Fatigue: unusual tiredness.

Serious or Rare Side Effects: - Allergic reactions: rash, angioedema, or hives. - Mood changes: depression, anxiety, or suicidal thoughts. - Hepatic enzyme elevation: abnormal liver function tests. - Stevens‑Johnson syndrome: severe skin reaction (very rare). - Bronchospasm worsening: paradoxical increase in airway constriction.

Montelukast sodium requires careful consideration in certain patient groups and conditions. - Pregnancy: Category B – use only if benefit outweighs potential risk. - Breastfeeding: monitor infant for possible effects. - Renal impairment: dose may need adjustment in severe cases. - Hepatic impairment: use with caution; monitor liver function. - Drug interactions: review concomitant medications for potential interactions. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Montelukast sodium can interact with several medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Ritonavir: may increase montelukast plasma concentrations. - Phenobarbital: may reduce montelukast effectiveness.

Moderate Interactions (Monitor Closely): - Fluconazole: may raise montelukast levels. - Carbamazepine: may lower montelukast exposure. - Warfarin: monitor INR as changes in metabolism are possible.